can compounded semaglutide still be sold | NextGenRx Compound Pharmacy The market for compounded GLP-1

It has demonstrated beneficial effects in treating energy impairments in several neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and Huntington's disease (reviewed by Adhihetty and Beal, G93A mice prevented loss of motor neurons, protected neurons from oxidative damage in the spinal cord, and improved motor performance and survival of mice in a dose dependent manner (Klivenyi et al., G93A mice was able to reduce NMDA induced release of glutamate in the cerebral cortex (Andreassen et al., G93A mice (Browne et al., 2004

M.QinJ.CarrollM

PMID 10874275

223,224 GLP-1 also inhibits glucagon release from -cells, which is beneficial for reducing blood glucose levels since glucagon promotes hepatic gluconeogenesis

The clinical evidence base for health claims associated with either precursor remains limited and inconsistent